Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.

Nature | 2017

Type 2 innate lymphoid cells (ILC2s) both contribute to mucosal homeostasis and initiate pathologic inflammation in allergic asthma. However, the signals that direct ILC2s to promote homeostasis versus inflammation are unclear. To identify such molecular cues, we profiled mouse lung-resident ILCs using single-cell RNA sequencing at steady state and after in vivo stimulation with the alarmin cytokines IL-25 and IL-33. ILC2s were transcriptionally heterogeneous after activation, with subpopulations distinguished by expression of proliferative, homeostatic and effector genes. The neuropeptide receptor Nmur1 was preferentially expressed by ILC2s at steady state and after IL-25 stimulation. Neuromedin U (NMU), the ligand of NMUR1, activated ILC2s in vitro, and in vivo co-administration of NMU with IL-25 strongly amplified allergic inflammation. Loss of NMU-NMUR1 signalling reduced ILC2 frequency and effector function, and altered transcriptional programs following allergen challenge in vivo. Thus, NMUR1 signalling promotes inflammatory ILC2 responses, highlighting the importance of neuro-immune crosstalk in allergic inflammation at mucosal surfaces.

Pubmed ID: 28902842 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: R01 AI074878
  • Agency: NIH HHS, United States
    Id: DP1 OD003930
  • Agency: NHLBI NIH HHS, United States
    Id: K08 HL130540
  • Agency: NCI NIH HHS, United States
    Id: U24 CA180922
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI056299
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI095466
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI130019
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI039671
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL122531
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI102942
  • Agency: NHGRI NIH HHS, United States
    Id: U01 HG004080
  • Agency: NIAID NIH HHS, United States
    Id: R21 AI087990
  • Agency: NIAID NIH HHS, United States
    Id: K08 AI123516
  • Agency: NIAID NIH HHS, United States
    Id: R21 AI083480
  • Agency: NCI NIH HHS, United States
    Id: R50 CA211461
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI095608
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI061570
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI097333
  • Agency: NHGRI NIH HHS, United States
    Id: U01 HG004085
  • Agency: NCCIH NIH HHS, United States
    Id: DP2 AT009499

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


International Mouse Phenotyping Consortium (IMPC) (tool)

RRID:SCR_006158

Center that produces knockout mice and carries out high-throughput phenotyping of each line in order to determine function of every gene in mouse genome. These mice will be preserved in repositories and made available to scientific community representing valuable resource for basic scientific research as well as generating new models for human diseases.

View all literature mentions